Metsera Inc. (MTSR)
NASDAQ: MTSR
· Real-Time Price · USD
26.95
-2.43 (-8.27%)
At close: Jun 16, 2025, 3:59 PM
27.22
0.99%
After-hours: Jun 16, 2025, 06:30 PM EDT
-8.27% (1D)
| Bid | 27.19 |
| Market Cap | 2.83B |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -161.21M |
| EPS (ttm) | -2.53 |
| PE Ratio (ttm) | -10.65 |
| Forward PE | -9.59 |
| Analyst | Buy |
| Ask | 27.25 |
| Volume | 945,896 |
| Avg. Volume (20D) | 1,063,020 |
| Open | 30.45 |
| Previous Close | 29.38 |
| Day's Range | 26.56 - 31.23 |
| 52-Week Range | 12.30 - 37.99 |
| Beta | 0.40 |
About MTSR
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol MTSR
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for MTSR stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 week ago
+15.5%
Metsera shares are trading higher after Guggenheim...
Unlock content with
Pro Subscription
1 week ago
+10.55%
Metsera shares are trading higher after the company announced topline data from the Phase 1 clinical trial of MET-233i.
